Characteristics of lymphoedema, in particular midline lymphoedema, after treatment for prostate cancer: a retrospective study.
Genital
Leg
Lymph node dissection
Lymphedema
Prostate cancer
Prostatectomy
Journal
BMC urology
ISSN: 1471-2490
Titre abrégé: BMC Urol
Pays: England
ID NLM: 100968571
Informations de publication
Date de publication:
04 Sep 2024
04 Sep 2024
Historique:
received:
17
01
2024
accepted:
02
07
2024
medline:
5
9
2024
pubmed:
5
9
2024
entrez:
4
9
2024
Statut:
epublish
Résumé
Patients undergoing treatment for prostate cancer may develop lymphoedema of the midline region. This has a substantial impact on a patient's quality of life and its diagnosis is often delayed or missed. Therefore, the purpose of this study is to compare the characteristics of patients with leg and midline lymphoedema to patients with only leg lymphoedema. We retrospectively collected patient-, cancer-, lymphoedema- and lymphoedema treatment-related data of 109 men with lymphoedema after treatment for prostate cancer. First, 42 characteristics were compared between both groups. Second, factors predicting presence of midline lymphoedema were explored by multivariable analyses. The mean age of the patients with lymphoedema was 68 ( ±7) years and mean BMI is 28 (±4) kg/m If patients with lymphoedema after prostate cancer do not have lower leg lymphoedema, have skin fibrosis, perform self-bandaging or self-manual lymphatic drainage, they possibly have midline lymphoedema.
Sections du résumé
BACKGROUND
BACKGROUND
Patients undergoing treatment for prostate cancer may develop lymphoedema of the midline region. This has a substantial impact on a patient's quality of life and its diagnosis is often delayed or missed. Therefore, the purpose of this study is to compare the characteristics of patients with leg and midline lymphoedema to patients with only leg lymphoedema.
METHODS
METHODS
We retrospectively collected patient-, cancer-, lymphoedema- and lymphoedema treatment-related data of 109 men with lymphoedema after treatment for prostate cancer. First, 42 characteristics were compared between both groups. Second, factors predicting presence of midline lymphoedema were explored by multivariable analyses.
RESULTS
RESULTS
The mean age of the patients with lymphoedema was 68 ( ±7) years and mean BMI is 28 (±4) kg/m
CONCLUSIONS
CONCLUSIONS
If patients with lymphoedema after prostate cancer do not have lower leg lymphoedema, have skin fibrosis, perform self-bandaging or self-manual lymphatic drainage, they possibly have midline lymphoedema.
Identifiants
pubmed: 39232687
doi: 10.1186/s12894-024-01533-5
pii: 10.1186/s12894-024-01533-5
doi:
Types de publication
Journal Article
Comparative Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
192Informations de copyright
© 2024. The Author(s).
Références
Sung H, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries, (in eng). CA Cancer J Clin. May 2021;71(3):209–49. https://doi.org/10.3322/caac.21660 .
Mottet N, EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update, et al. Part 1: screening, diagnosis, and local treatment with curative intent, (in eng). Eur Urol. Feb 2021;79(2):243–62. https://doi.org/10.1016/j.eururo.2020.09.042 .
Briganti A et al. Pelvic lymph node dissection in prostate cancer, (in eng). Eur Urol. Jun 2009;55(6):1251–665. https://doi.org/10.1016/j.eururo.2009.03.012 .
Fossati N, et al. The benefits and Harms of different extents of Lymph Node Dissection during Radical Prostatectomy for prostate Cancer: a systematic review. Eur Urol. 2017;72(1):84–109. https://doi.org/10.1016/j.eururo.2016.12.003 .
doi: 10.1016/j.eururo.2016.12.003
pubmed: 28126351
Keegan KA, Cookson MS. Complications of pelvic lymph node dissection for prostate Cancer. Curr Urol Rep. 2011;12(3):203–8. https://doi.org/10.1007/s11934-011-0179-z .
doi: 10.1007/s11934-011-0179-z
pubmed: 21394597
Ploussard G et al. Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature, (in eng). Eur Urol. Jan 2014;65(1):7–16. https://doi.org/10.1016/j.eururo.2013.03.057 .
The diagnosis and treatment of peripheral lymphedema. 2020 Consensus Document of the International Society of Lymphology, (in eng), Lymphology. 2020;53(1):3–19.
Bowman C, Piedalue KA, Baydoun M, Carlson LE. The Quality of Life and Psychosocial implications of Cancer-related Lower-Extremity Lymphedema: a systematic review of the literature, (in eng). J Clin Med. Oct 2 2020;9(10). https://doi.org/10.3390/jcm9103200 .
Clinckaert A et al. The Prevalence of Lower Limb and Genital Lymphedema after Prostate Cancer Treatment: A Systematic Review, (in eng). Cancers (Basel). Nov 2022;14(22):5667. https://doi.org/10.3390/cancers14225667 .
Hidding JT, Viehoff PB, Beurskens CH, van Laarhoven HW, M. W. Nijhuis-van der Sanden, and, van der Wees PJ. Measurement Properties of Instruments for Measuring of Lymphedema: Systematic Review, (in eng). Phys Ther. Dec 2016;96(12):1965–1981. https://doi.org/10.2522/ptj.20150412 .
Rhian Noble-Jones MJT, Pradeep Bose MBBS, FRCSEd. The Lymphoedema Genitourinary Cancer Questionnaire in urology follow-up clinics. INt J Urol Nurs vol. 2019;13(1):5–12. https://doi.org/10.1111/ijun.12174 .
doi: 10.1111/ijun.12174
Rubin DB. Multiple imputation for nonresponse in surveys. John Wiley Sons Inc New York. 1987. https://doi.org/10.1002/9780470316696 .
doi: 10.1002/9780470316696
Neuberger M, et al. Onset and burden of lower limb lymphedema after radical prostatectomy: a cross-sectional study, (in eng). Support Care Cancer. Feb 2022;30(2):1303–13. https://doi.org/10.1007/s00520-021-06520-2 .
Simon L, Trévidic P, Denis P, Vignes S. Vulvar lymphangioma circumscriptum: comparison of primary and acquired forms in a cohort of 57 patients, (in eng). J Eur Acad Dermatol Venereol. Feb 2018;32(2):e56–8. https://doi.org/10.1111/jdv.14497 .
Sudduth CL, Greene AK. Lymphedema and Obesity, (in eng). Cold Spring Harb Perspect Med. May 2022;12(5). https://doi.org/10.1101/cshperspect.a041176 .
Labropoulos N, Raiker A, Gasparis A, Weycker D, O’Donnell T Jr. Clinical impact of severe obesity in patients with Lymphoedema, (in eng). Eur J Vasc Endovasc Surg Nov. 2022;17. https://doi.org/10.1016/j.ejvs.2022.11.014 .
Ridner SH, Dietrich MS, Stewart BR, Armer JM. Body mass index and breast cancer treatment-related lymphedema, (in eng). Support Care Cancer. Jun 2011;19(6):853–57. https://doi.org/10.1007/s00520-011-1089-9 .
Vignes S. Genital Lymphedema after Cancer Treatment: A Narrative Review, (in eng). Cancers (Basel). Nov 2022;14(23):5809. https://doi.org/10.3390/cancers14235809 .
Talari K, Goyal M. Retrospective studies - utility and caveats, (in eng). J R Coll Physicians Edinb. Dec 2020;50(4):398–402. https://doi.org/10.4997/jrcpe.2020.409 .
Noble-Jones TM, Quéré R, Moff att I, Borman C, DiCecco P S, and, Gabe-Walters GK, Bragg M, Morgan T. K, Genital oedema. J Wound Care. Sup 2021;30(12):1–40.